These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35069414)

  • 1. Iron Deposition in Gray Matter Nuclei of Patients With Intracranial Artery Stenosis: A Quantitative Susceptibility Mapping Study.
    Mao H; Dou W; Wang X; Chen K; Wang X; Guo Y; Zhang C
    Front Neurol; 2021; 12():785822. PubMed ID: 35069414
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
    Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
    Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
    Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
    Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
    Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
    J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
    Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
    J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease.
    Du L; Zhao Z; Cui A; Zhu Y; Zhang L; Liu J; Shi S; Fu C; Han X; Gao W; Song T; Xie L; Wang L; Sun S; Guo R; Ma G
    ACS Chem Neurosci; 2018 Jul; 9(7):1849-1857. PubMed ID: 29722955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
    Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
    Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
    Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
    Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.
    Li Y; Sethi SK; Zhang C; Miao Y; Yerramsetty KK; Palutla VK; Gharabaghi S; Wang C; He N; Cheng J; Yan F; Haacke EM
    Front Neurosci; 2020; 14():607705. PubMed ID: 33488350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative susceptibility mapping to evaluate brain iron deposition and its correlation with physiological parameters in hypertensive patients.
    Li X; Jin D; Zhu Y; Liu L; Qiao Y; Qian Y; Tian J; Jiang B; Hou C; Geng J; Li X; Gao X; Ma Y; Wang S; Zong J; Qin Y
    Ann Transl Med; 2021 Oct; 9(20):1582. PubMed ID: 34790788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and sex related differences in subcortical brain iron concentrations among healthy adults.
    Persson N; Wu J; Zhang Q; Liu T; Shen J; Bao R; Ni M; Liu T; Wang Y; Spincemaille P
    Neuroimage; 2015 Nov; 122():385-98. PubMed ID: 26216277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
    Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
    J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different iron deposition patterns in hemodialysis patients with and without restless legs syndrome: a quantitative susceptibility mapping study.
    Wang H; Han X; Jin M; Wang LY; Diao ZL; Guo W; Zhang P; Wang Z; Ding HY; Lv H; Zhang ZY; Zhao PF; Li J; Yang ZH; Liu WH; Wang ZC
    Sleep Med; 2020 May; 69():34-40. PubMed ID: 32045852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
    Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
    J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
    Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
    Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker.
    Sun Y; Ge X; Han X; Cao W; Wang Y; Ding W; Cao M; Zhang Y; Xu Q; Zhou Y; Xu J
    Front Aging Neurosci; 2017; 9():81. PubMed ID: 28424610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.